Please confirm you are human

This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.

A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.

Hold with a pointer, or hold Space or Enter.

News

firstwordpharma.com
firstwordpharma.com > story > 7973027

Friday Five??? Novartis' stumbles spark boardroom backlash, Nodthera name drops, FDA throws wrench into Biohaven deal???and more

3+ day, 12+ hour ago   (19+ words) Friday Five – Novartis' stumbles spark boardroom backlash, Nodthera name drops, FDA throws wrench into Biohaven deal…and more firstwordpharma.com...

firstwordpharma.com
firstwordpharma.com > story > 7958314

Vital Signs: Who's enjoying the fruits of pharma's labor?

6+ day, 19+ hour ago   (10+ words) firstwordpharma.com...

FirstWord Pharma
firstwordpharma.com > story > 7957227

Clover posts upbeat mid-stage data for respiratory vaccine combos

1+ week, 5+ hour ago   (11+ words) FirstWord Pharma...

FirstWord Pharma
firstwordpharma.com > story > 7937337

GSK takes dual-target mRNA flu shot to Phase III

1+ week, 5+ day ago   (11+ words) FirstWord Pharma...

FirstWord Pharma
firstwordpharma.com > story > 7935226

Novartis pauses immunology, neuro CAR-T studies after three patient deaths

1+ week, 6+ day ago   (12+ words) FirstWord Pharma...

FirstWord Pharma
firstwordpharma.com > story > 7911230

'Unprecedented' cure rate for GSK's hep B therapy prompts Japan approval

2+ week, 6+ day ago   (13+ words) FirstWord Pharma...

FirstWord Pharma
firstwordpharma.com > story > 7899634

Friday Five??? Cancer vaccine aims hit target, MAHA mainstay tapped to run FDA, AstraZeneca's hits soften a miss???and more

3+ week, 3+ day ago   (22+ words) Friday Five – Cancer vaccine aims hit target, MAHA mainstay tapped to run FDA, AstraZeneca's hits soften a miss…and more FirstWord Pharma...

FirstWord Pharma
firstwordpharma.com > story > 7896336

Spotlight On: mRNA breaks from vaccine stable as Moderna, Merck & Co. deliver breakthrough melanoma results

3+ week, 4+ day ago   (17+ words) FirstWord Pharma...

FirstWord Pharma
firstwordpharma.com > story > 7896231

Vital Signs: Merck enters Moderna???s latest vaccine bubble

3+ week, 4+ day ago   (10+ words) Vital Signs: Merck enters Moderna’s latest vaccine bubble FirstWord Pharma...

FirstWord Pharma
firstwordpharma.com > story > 7895551

Tolerance continues thymus portfolio buildout with NeoImmune licensing deal

3+ week, 4+ day ago   (11+ words) FirstWord Pharma...